10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026)
10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.40 Bn | 24.09 Bn | 662.02 Mn | -16.04% |
| 2 | BrightSpring Health Services | 14.85 Bn | 13.95 Bn | 482.22 Mn | 91.54% |
| 3 | Healthequity | 8.13 Bn | 7.87 Bn | 256.31 Mn | 411.55% |
| 4 | 10x Genomics | 6.04 Bn | 5.50 Bn | 106.18 Mn | -70.42% |
| 5 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 6 | MiniMed | 4.46 Bn | 4.16 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.42 Bn | 4.35 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.89 Bn | 3.14 Bn | 125.97 Mn | -63.51% |
| 9 | Privia Health | 3.19 Bn | 2.77 Bn | - | -25.65% |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | -43.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.42% |
| Dec 31, 2025 | -47.35% |
| Sep 30, 2025 | -26.09% |
| Jun 30, 2025 | -27.21% |
| Mar 31, 2025 | -59.33% |
| Dec 31, 2024 | -32.03% |
| Sep 30, 2024 | -61.11% |
| Jun 30, 2024 | 28.55% |
| Mar 31, 2024 | -63.44% |
| Dec 31, 2023 | 26.67% |
| Sep 30, 2023 | -36.57% |
| Jun 30, 2023 | 148.40% |
| Mar 31, 2023 | 17.49% |
| Dec 31, 2022 | 178.84% |
| Sep 30, 2022 | 62.44% |
| Jun 30, 2022 | 12.19% |
| Mar 31, 2022 | 105.76% |
| Dec 31, 2021 | 167.07% |